In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol

Background: The developing fetus is particularly vulnerable to the effects of endocrine disrupting chemicals (EDCs). Molecular fingerprints of EDCs can be identified via microRNA (miRNA) expression profiles and may be etiologically implicated in the developmental origin of disease (DOHaD). Methods/...

Full description

Bibliographic Details
Main Authors: Tricia L. Larose, Pål Sætrom, Marit P. Martinussen, Håkon Skogseth, Torkjel M. Sandanger, Ghislaine Scelo, Cliona M. McHale, Geir W. Jacobsen, Martyn T. Smith
Format: Article
Language:English
Published: SAGE Publishing 2019-09-01
Series:Journal of Public Health Research
Subjects:
Online Access:https://www.jphres.org/index.php/jphres/article/view/1550
_version_ 1797971093396389888
author Tricia L. Larose
Pål Sætrom
Marit P. Martinussen
Håkon Skogseth
Torkjel M. Sandanger
Ghislaine Scelo
Cliona M. McHale
Geir W. Jacobsen
Martyn T. Smith
author_facet Tricia L. Larose
Pål Sætrom
Marit P. Martinussen
Håkon Skogseth
Torkjel M. Sandanger
Ghislaine Scelo
Cliona M. McHale
Geir W. Jacobsen
Martyn T. Smith
author_sort Tricia L. Larose
collection DOAJ
description Background: The developing fetus is particularly vulnerable to the effects of endocrine disrupting chemicals (EDCs). Molecular fingerprints of EDCs can be identified via microRNA (miRNA) expression profiles and may be etiologically implicated in the developmental origin of disease (DOHaD). Methods/design: This pilot study includes pregnant women at high risk (smoking at conception), and low risk (non-smoking at conception) for SGA birth (birthweight<10th percentile for gestational age). We have randomly selected 12 mothers (3 high-risk SGA birth, 3 low-risk SGA birth, 3 high-risk non-SGA birth, 3 low-risk non-SGA birth), with EDC measurements from gestational week 17. All offspring are female. We aim to test the stability of our samples (maternal serum, cord blood, placenta tissue), observe the differential expression of miRNA profiles over time (gestational weeks 17, 25, 33, 37, birth), and study the consistency between maternal EDC measures and miRNA expression profiles across our repeated measures. Expected impact of the study for Public Health: Results from this pilot study will inform the development of a larger cohort wide analysis, and will impact the current state of knowledge in the fields of public health, epigenetics, and the DOHaD.
first_indexed 2024-04-11T03:27:15Z
format Article
id doaj.art-aff491e4ffc0439786fc221235f63abf
institution Directory Open Access Journal
issn 2279-9028
2279-9036
language English
last_indexed 2024-04-11T03:27:15Z
publishDate 2019-09-01
publisher SAGE Publishing
record_format Article
series Journal of Public Health Research
spelling doaj.art-aff491e4ffc0439786fc221235f63abf2023-01-02T07:13:53ZengSAGE PublishingJournal of Public Health Research2279-90282279-90362019-09-018210.4081/jphr.2019.1550In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocolTricia L. Larose0Pål Sætrom1Marit P. Martinussen2Håkon Skogseth3Torkjel M. Sandanger4Ghislaine Scelo5Cliona M. McHale6Geir W. Jacobsen7Martyn T. Smith8K.G. Jebsen Center for Genetic Epidemiology, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim1K.G. Jebsen Center for Genetic Epidemiology, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim; Department of Computer Science, Faculty of Information Technology and Electrical Engineering, Norwegian University of Science and Technology, Trondheim; Bioinformatics core facility – BioCore, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, TrondheimDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, TrondheimBiobank 1, St. Olavs University Hospital, TrondheimDepartment of Community Medicine, Faculty of Health Sciences, UiT-the Arctic University of Norway, TromsøGenetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer, World Health Organization, LyonDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, CADepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, TrondheimDivision of Environmental Health Sciences, School of Public Health, University of California, Berkeley, CABackground: The developing fetus is particularly vulnerable to the effects of endocrine disrupting chemicals (EDCs). Molecular fingerprints of EDCs can be identified via microRNA (miRNA) expression profiles and may be etiologically implicated in the developmental origin of disease (DOHaD). Methods/design: This pilot study includes pregnant women at high risk (smoking at conception), and low risk (non-smoking at conception) for SGA birth (birthweight<10th percentile for gestational age). We have randomly selected 12 mothers (3 high-risk SGA birth, 3 low-risk SGA birth, 3 high-risk non-SGA birth, 3 low-risk non-SGA birth), with EDC measurements from gestational week 17. All offspring are female. We aim to test the stability of our samples (maternal serum, cord blood, placenta tissue), observe the differential expression of miRNA profiles over time (gestational weeks 17, 25, 33, 37, birth), and study the consistency between maternal EDC measures and miRNA expression profiles across our repeated measures. Expected impact of the study for Public Health: Results from this pilot study will inform the development of a larger cohort wide analysis, and will impact the current state of knowledge in the fields of public health, epigenetics, and the DOHaD.https://www.jphres.org/index.php/jphres/article/view/1550environmental healthendocrine disrupting chemicalsfetal growthmiRNA
spellingShingle Tricia L. Larose
Pål Sætrom
Marit P. Martinussen
Håkon Skogseth
Torkjel M. Sandanger
Ghislaine Scelo
Cliona M. McHale
Geir W. Jacobsen
Martyn T. Smith
In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol
Journal of Public Health Research
environmental health
endocrine disrupting chemicals
fetal growth
miRNA
title In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol
title_full In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol
title_fullStr In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol
title_full_unstemmed In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol
title_short In utero exposure to endocrine disrupting chemicals, micro-RNA profiles, and fetal growth: a pilot study protocol
title_sort in utero exposure to endocrine disrupting chemicals micro rna profiles and fetal growth a pilot study protocol
topic environmental health
endocrine disrupting chemicals
fetal growth
miRNA
url https://www.jphres.org/index.php/jphres/article/view/1550
work_keys_str_mv AT triciallarose inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT palsætrom inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT maritpmartinussen inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT hakonskogseth inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT torkjelmsandanger inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT ghislainescelo inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT clionammchale inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT geirwjacobsen inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol
AT martyntsmith inuteroexposuretoendocrinedisruptingchemicalsmicrornaprofilesandfetalgrowthapilotstudyprotocol